-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Prime Medicine to Neutral

Benzinga·05/20/2025 10:57:18
Listen to the news
HC Wainwright & Co. analyst Arthur He downgrades Prime Medicine (NASDAQ:PRME) from Buy to Neutral.